H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.9% of adults in New York have diagnosed diabetes — about even with the U.S. 12% figure. Census population 8,336,817. New York Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed New York clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a New York storefront.
Diabetic Wound Care That Delivers in New York, NY for clinics & physicians. Specialized diabetic wound car… Compliance support & pricing — contact Hawk Medical.
Adult obesity in New York is 25.1% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 11.9% of adults in New York have diagnosed diabetes — about even with the U.S. 12% figure. New York is outside CDC’s core Diabetes Belt list; use the PLACES city rate anyway. Hawk Medical is the distributor for diabetic wound care, not a walk-in clinic.
National Diabetic Wound Care That Delivers notes (how the product actually works)JK reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in New York is 11.9% or not. PLACES is planning data. The LCD is the claim.
We are not going to invent a New York warehouse or a five-star local review. What you get is diabetic wound care from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JK, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 11.9% of adults — about even with the U.S. 12% figure. Obesity is 25.1%; arthritis is 19.9%. That is place-level BRFSS modeling, not a clinic census and not a New York trial.
CDC estimates 12% of the U.S. population has diabetes (40.1 million people, 2023). America's Health Rankings (BRFSS 2024) shows state adult rates from Colorado 8.4% to West Virginia 18.4%. We do not publish a made-up city diabetes count. Use national/state published rates plus your panel.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a New York compliance risk.
No. They are B2B distribution pages for licensed providers. Patients in New York should speak with their clinician, not use a distributor URL as care instructions.
Ask for the IFU, the lot-traceability packet, and the National Government Services (NGS) article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a New York fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in New York, NY.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for New York is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for New York — about even with the U.S. 12% figure. Planning input, not an outcomes claim.
New York Part B wound biologics follow this contractor (siblings: CT, MA, ME, NH, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in New York. Useful for joint-program math; still needs a diagnosis and privileging.
No New York storefront. Joe Bradley is an active practice owner. diabetic wound care stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.